Regenerative Biologics Supplier for Orthopedic Practices in Columbia, SC

How Orthopedic Groups Typically Qualify a Biologics Vendor

Orthopedic practices and surgery centers generally run a documented vendor review before adding a new biologics line. That review commonly includes confirming the supplier's distribution registration status, requesting a certificate of analysis and donor eligibility summary for the specific lot being considered, and routing the materials to a compliance officer or medical director for sign-off.

Because Wharton's jelly allografts and exosome products sit under different regulatory frameworks, many groups ask their vendor to clarify which framework applies to each product line before purchasing, and to confirm that documentation can be produced on a per-lot basis rather than as a general claim.

• Certificate of analysis per lot
• Donor eligibility summary
• Confirmation of applicable regulatory framework

NPI Verification and Account Setup

Precision Biologics requires an NPI number to open a purchasing account, consistent with standard practice for distributors selling exclusively to licensed professionals. Account setup typically involves confirming the practice's NPI record against the NPPES registry, verifying the ordering physician or medical director, and establishing a point of contact for ongoing documentation requests.

Group practices with multiple locations can register each NPI separately so that lot traceability stays tied to the correct practice address and ordering clinician.

Cold Chain Shipping Into the Southeast

Cryopreserved products ship overnight on dry ice in validated containers, with storage maintained at -80 degrees Celsius prior to shipment. Practices receiving shipments in South Carolina should have a staff member available to log receipt, confirm the shipping container held temperature, and move the product into appropriate storage without delay.

Lyophilized formats do not require cryogenic shipping, which some practices factor into receiving logistics when a location has limited cold storage capacity.

Medical Director Review and Ongoing Support

Because intended-use determinations are specific to each practice, Precision Biologics recommends that the medical director or supervising physician review product documentation with the practice's own regulatory counsel before incorporating a new line, and verify standing with the South Carolina medical board as part of normal credentialing. Our team is available for physician-level calls focused on documentation and product specifications, not clinical guidance, and can walk a new account through the verification and ordering process.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.